DIOVAN Drug Profile

Name: hydrochlorothiazide; valsartan
Brand: DIOVAN

« Back to Dashboard

What is the patent landscape for Diovan, and what generic Diovan alternatives are available?

Diovan is a drug marketed by Novartis and is included in three NDAs. There are two patents protecting this drug and three Paragraph IV challenges.

This drug has eighty-eight patent family members in thirty-three countries.

The generic ingredient in DIOVAN is hydrochlorothiazide; valsartan. There are thirty-one drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; valsartan profile page.

Summary for Tradename: DIOVAN

Patents:	2
Applicants:	1
NDAs:	3
Suppliers / Packagers: see list	11
Bulk Api Vendors: see list	85
Clinical Trials: see list	10
Patent Applications: see list	6,212
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	DIOVAN at DailyMed

Pharmacology for Tradename: DIOVAN

Drug Class	Angiotensin 2 Receptor Blocker
Mechanism of Action	Angiotensin 2 Receptor Antagonists

ADD ALERT

Glossary

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Delist Req.	Exclusivity Expiration
Novartis	DIOVAN	valsartan	CAPSULE;ORAL	020665-001	Dec 23, 1996		DISCN	No	No		► Subscribe		► Subscribe
Novartis	DIOVAN	valsartan	TABLET;ORAL	021283-002	Jul 18, 2001	AB	RX	Yes	No	5,972,990*PED	► Subscribe	Y	► Subscribe
Novartis	DIOVAN	valsartan	TABLET;ORAL	021283-004	Aug 14, 2002	AB	RX	Yes	No	6,294,197*PED	► Subscribe	Y	► Subscribe
Novartis	DIOVAN HCT	hydrochlorothiazide; valsartan	TABLET;ORAL	020818-002	Mar 6, 1998	AB	RX	Yes	No	6,294,197*PED	► Subscribe	Y	► Subscribe
Novartis	DIOVAN	valsartan	TABLET;ORAL	021283-002	Jul 18, 2001	AB	RX	Yes	No	6,294,197*PED	► Subscribe	Y	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

Analyze global market entry opportunities
Predict branded drug patent expiration
Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

Available with subscription

Paragraph IV Activity

Available with subscription

Patent Maintenance

Available with subscription

Non-Orange Book Patents

Available with subscription

International Patents

Available with subscription

Supplementary Protection Certificates

Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

DIOVAN Drug Profile

« Back to Dashboard

Summary for Tradename: DIOVAN

Pharmacology for Tradename: DIOVAN

Glossary

Subscribe for Complete Access

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Get our Free Drug Patent Bulletin